CCN2 and CCN3 belong to the CCN family of proteins, which show a high level of structural similarity.Previous studies have shown that CCN2 mediates the ability of transforming growth factor (TGF)β to stimulate collagen synthesis, leading to keloid formation. CCN2 and CCN3
are opposing factors in regulating the promoter activity and secretion of this extracellular matrix (ECM) protein. Thus, we hypothesize that CCN3 possesses an antiscarring effect. However, the exact mechanism of CCN3 in this antiscarring effect remains unclear. The aim of this study was
to investigate the mechanism of CCN3 in reducing scar formation. Palatal fibroblasts were obtained from the explants of the oral palatal mucosa of 8weekold male SpragueDawley rats. CCN3 overexpression vector was constructed and then transfected into cells. The inhibitory effects of CCN3 on
cell growth were detected via the 3(4,5dimethylthiazol2yl)2,5diphenyltetrazolium bromide (MTT) assay. Apoptosis was measured using an Annexin Vfluorescein isothiocyanate (FITC)/propidium iodide (PI) apoptosis detection kit and flow cytometry. The expression levels of collagen I,
collagen III and αsmooth muscle actin (αSMA) were determined by western blot analysis and RTPCR. Following treatment with TGFβ1, we detected the expression of CCN3 and Smad1 in the fibroblasts. CCN3 significantly inhibited the growth and induction of apoptosis of
fibroblasts. The expression of collagen I, collagen III and αSMA was lower in the CCN3transfected group as compared to the control and vector groups. TGFβ1 stimulation efficiently suppressed the expression of CCN3 at the mRNA and protein levels, and CCN3 was required for
TGFβ1induced Smad1 phosphorylation. Results of this study demonstrated that CCN3 is involved in the proliferation and apoptosis of fibroblasts and the synthesis of ECM proteins. Therefore, CCN3 may play an important role in the development of scar tissue, and may represent a novel therapeutic
target for reducing scar formation.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
Document Type: Research Article
Department of CranioMaxillofacial Trauma Plastic Surgery, Stomatology Hospital of Xi'an Jiaotong University College of Medicine, Xi'an, Shaanxi 710004, P.R. China
Department of Orthodontics, Stomatology Hospital of Xi'an Jiaotong University College of Medicine, Xi'an, Shaanxi 710004, P.R. China
Publication date: June 1, 2014
More about this publication?
The International Journal of Molecular Medicine is a monthly, peer-reviewed journal devoted to the publication of high quality studies related to the molecular mechanisms of human disease. The journal welcomes research on all aspects of molecular and clinical research, ranging from biochemistry to immunology, pathology, genetics, human genomics, microbiology, molecular pathogenesis, molecular cardiology, molecular surgery and molecular psychology.
The International Journal of Molecular Medicine aims to provide an insight for researchers within the community in regard to developing molecular tools and identifying molecular targets for the diagnosis and treatment of a diverse number of human diseases.
- Editorial Board
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Information for Advertisers
- Terms & Conditions
- Ingenta Connect is not responsible for the content or availability of external websites